Common use of Non-Suspicion-Based Post Clause in Contracts

Non-Suspicion-Based Post. Accident Testing Non-suspicion-based post-accident testing is defined as urine drug testing as a result of an accident which meets the definition of an accident as outlined in the Federal Motor Carrier Safety Regulations. Urine drug testing will be required after accidents meeting the following conditions and drivers are required to remain readily available for testing for thirty-two (32) hours following the accident or until tested. Employees subject to non-suspicion-based post-accident drug testing shall be limited to those employees subject to DOT drug testing, who are involved in an accident where there is: (i) a fatality, or; (ii) a citation under State or local law is issued to the driver for a moving traffic violation arising from the accident in which: (a) bodily injury to a person who, as a result of the injury, immediately receives medical treatment away from the scene of the accident, or (b) one or more motor vehicles incurring disabling damage as a result of the accident, requires the vehicle(s) to be transported away from the scene by a tow truck or other vehicle. The driver has the responsibility to make himself/herself available for urine drug testing within the thirty-two (32) hour period in accordance with the procedures outlined in this Subsection. The driver is responsible to notify the Employer upon receipt of a citation and to note receipt thereof on the accident report. Failure to so notify the Employer shall subject the driver to disciplinary action. If a driver receives a citation for a moving violation more than thirty- two (32) hours after a reportable accident, he/she shall not be required to submit to post-accident urine drug testing. The Employer shall make available a urine drug testing kit and an appropriate collection site for the driver to provide specimens. The provisions of Section 1 F 3 (Split Sample Procedures), and Section 1 J 1 (One-Time Rehabilitation), shall apply to non-suspicion-based post-accident urine drug testing.

Non-Suspicion-Based Post. Accident Testing Non-suspicion-based post-accident testing is defined as urine drug testing as a result of an accident which meets the definition of an accident as outlined in the Federal Motor Carrier Safety Regulations. Urine drug testing will be required after accidents meeting the following conditions and drivers are required to remain readily available for testing for thirty-two (32) hours following the accident or until tested. Employees subject to non-suspicion-based post-accident drug testing shall be limited to those employees subject to DOT drug testing, who are involved in an accident where there is: (i) a fatality, or; (ii) a citation under State or local law is issued to the driver for a moving traffic violation arising from the accident in which: (a) bodily injury to a person who, as a result of the injury, immediately receives medical treatment away from the scene of the accident, or (b) one or more motor vehicles incurring disabling damage as a result of the accident, requires the vehicle(s) to be transported away from the scene by a tow truck or other vehicle. The driver has the responsibility to make himself/herself available for urine drug testing within the thirty-two (32) hour period in accordance with the procedures outlined in this Subsection. The driver is responsible to notify the Employer upon receipt of a citation and to note receipt thereof on the accident report. Failure to so notify the Employer shall subject the driver to disciplinary action. If a driver receives a citation for a moving violation more than thirty- thirty-two (32) hours after a reportable accident, he/she shall not be required to submit to post-accident urine drug testing. The Employer shall make available a urine drug testing kit and an appropriate collection site for the driver to provide specimens. The provisions of Article 35, Section 1 3 F 3 (Split Sample Procedures), and Article 35, Section 1 3 J 1 (One-Time Rehabilitation), shall apply to non-suspicion-based post-accident urine drug testing.